Arrowhead Pharmaceuticals Inc. (ARWR) Tops Q2 EPS by 320c
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $89.41 --0%
Financial Fact:
General and administrative expenses: 2.28M
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
General and administrative expenses: 2.28M
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q2 EPS of $2.75, $3.20 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $542.71 million versus the consensus estimate of $127.9 million.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance
- Performance Food Group to shrink board to 10 directors in 2026
- Veeva Systems (VEEV) PT Raised to $276 at Guggenheim
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
